BioAmber Inc fka BIOAQ

[youngster-moon]

Unfortunately this theory is not supported by documents. Actually there is proof of the complete opposite of what was said.

Let us for minute accept the notion that there is some of the A/R atill outstanding?

It still would not pay off the creditors and the shareholders still get nothing.

So I'm curious and have a few questions.
1. If all the A/R was collected how would someone be the collector of the A/R? shouldn't it be zero if the FACE VALUE of $14M dollars was collected?



IE post: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156564460



2. "This would not only allow the creditors to move on," referring to the quote above about it would no pay off the creditors, the document says the complete opposite or is it photo-shopped? Not to mention it would also assist in establishing a profitable model going forward. Does that implying that there is extra money after creditors?



3. How about the inventory and how it will be sold at increased values in a non distress sale scenario. Does that mean more than enough money for creditors?



4. If you were purchasing assets of a company wouldn't you be the future operating company? I never knew documents talked in third person. So who will we be settling the A/R that hasn't been collected?



So,

Let us for minute accept the notion that there is some of the A/R atill outstanding?

It still would not pay off the creditors and the shareholders still get nothing

Is far from the truth if you read the supporting documents.



Here's an idea why everything wasn't collected, why there will be money left over after creditors, why there is a future operating company and why Bioamber is such a popular stock.





P.S. Why do you think creditors did not complain about receiving less the the scrap value of the plant, 1/11th of the distressed liquidation price, and refused for a shareholder to pay out of their own pocket to try and get creditors more money?